Zaklady Przemyslu Mieszko S.A.- Company Capsule (Related Reports)

Zaklady Przemyslu Mieszko S.A.- Company Capsule


November 26, 2011
21 Pages - SKU: ICDR6690127
License type:
Online Download      US $75.00
Global Site License      US $225.00
Chimerix, Inc. - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
Chimerix, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Chimerix, Inc. - Product Pipeline Review - 2014’, provides an overview of the Chimerix, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
$1,500.00
Anergis SA - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
Anergis SA - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Anergis SA - Product Pipeline Review - 2014’, provides an overview of the Anergis SA’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
$1,500.00
Zalaris - Multi-Process HR Outsourcing
2/14/2014 | published by: NelsonHall
Zalaris - Multi-Process HR Outsourcing Who Is This Vendor Assessment For? NelsonHall’s Multi-Process HR Outsourcing (MPHRO) Vendor Assessment for Zalaris is a comprehensive assessment of Zalaris’ MPHRO offering and capabilities designed for:  |  read more...
$1,200.00
i360medical Limited - Product Pipeline Analysis, 2013 Update
1/20/2014 | published by: GlobalData
i360medical Limited - Product Pipeline Analysis, 2013 Update Summary i360medical Limited (i360medical), formerly known as The Centre for Innovation in Surgical Technology, is a new healthcare solutions and medical device innovation company. It acts both, as a  |  read more...
$750.00
UChicago Argonne, LLC - Product Pipeline Analysis, 2013 Update
1/20/2014 | published by: GlobalData
UChicago Argonne, LLC - Product Pipeline Analysis, 2013 Update Summary UChicago Argonne, LLC (UChicago Argonne) is a research and technologies development company. The company operates the U.S. Department of Energy's Argonne National Laboratory. Its Argonne National Laboratory  |  read more...
$750.00
Dynasil Corporation of America (DYSL) - Product Pipeline Analysis, 2013 Update
1/20/2014 | published by: GlobalData
Dynasil Corporation of America (DYSL) - Product Pipeline Analysis, 2013 Update Summary Dynasil Corporation of America (Dynasil) is a technology service provider. The company develops, manufactures and markets detection, sensing and analysis technology, optical components and precision  |  read more...
$750.00
Zenotech Laboratories Limited - Product Pipeline Review - 2013
12/31/2013 | published by: Global Markets Direct
Zenotech Laboratories Limited - Product Pipeline Review - 2013 Summary Global Market Direct’s pharmaceuticals report, “Zenotech Laboratories Limited - Product Pipeline Review - 2013” provides data on the Zenotech Laboratories Limited’s research and development focus. The report  |  read more...
$1,500.00
Genera Biosystems Limited (GBI) - Product Pipeline Analysis, 2013 Update
12/31/2013 | published by: GlobalData
Summary Genera Biosystems Limited (GBL) is a diagnostic product company. The company develops and commercializes multiplexed molecular diagnostic testing products. Its products include RTIplex and PapType. GBL’s RTIplex is a multiplexed and automated PCR based test  |  read more...
$750.00
Biglari Holdings Inc.: Competitive Benchmarking Report
1/1/2014 | published by: The Business Analysts' Group
This report compares the company with its closest competitors on various parameters such as business segments, product offerings & their USPs (unique selling points), geographical coverage, financial performance, M&A developments and business strategies.  |  read more...
$1,799.00
BP Prudhoe Bay Royalty Trust: Competitive Benchmarking Report
1/1/2014 | published by: The Business Analysts' Group
This report compares the company with its closest competitors on various parameters such as business segments, product offerings & their USPs (unique selling points), geographical coverage, financial performance, M&A developments and business strategies.  |  read more...
$1,799.00